Market Overview

2018 Global Healthcare Licensing - Non-Listed on Stock Exchanges Trends: Biotech (Privately-owned Companies) Mid-Year Review - ResearchAndMarkets.com

Share:

The "Global
Healthcare Licensing - Non-Listed on Stock Exchanges Trends: Biotech
(Privately-owned Companies) Mid-Year Review"
report has been
added to ResearchAndMarkets.com's offering.

This mid-year review report brings at one place all licensing deals and
negotiations that took place between the privately-owned biotech
companies of Japan, US and Europe during January 1, 2018 to June 30,
2018.

Further, the licensing deals and negotiations that took place between
the privately-owned biotech companies of other select regions and Japan,
US and Europe during this period are also studied and included here.

Also, the licensing deals and negotiations that took place within the
privately-owned biotech companies of Japan, US and Europe as well as
within the privately-owned biotech companies of countries/regions other
than Japan, US and Europe are studied and included here.

Moreover, all this collected data is comprehensively analyzed to
understand the licensing trends and directions among the privately-owned
companies during this time period.

Key Features

  • 6 months' Japan-US-Europe licensing transactions of privately-owned
    biotech companies at one place
  • 6 months' other select regions licensing transactions of
    privately-owned biotech companies at one place
  • Curated categorizations of licensing details
  • 8+ variables reflecting different forms of transactions done
  • Canada/Australia/NZ licensing trends of privately-owned biotech
    companies with Japan-US-Europe covered
  • Emerging markets licensing trends of privately-owned biotech companies
    with Japan-US-Europe covered
  • Licensing trends of privately-owned biotech companies within Japan,
    US, Europe; and also within other select regions covered
  • Licensing trends and directions of privately-owned biotech companies
    summarized

Key Analysis Provided

  • Total number of licensing deals of privately-owned biotech companies
    signed
  • Total number of privately-owned biotech companies involved in
    licensing deals
  • Most licensing deals signed by which country's privately-owned biotech
    companies
  • Number of inbound and outbound licensing deals of privately-owned
    biotech companies
  • Most licensing deals signed by which medicine groups
  • Licensing payment arrangements most followed in the global licensing
    deals of privately-owned biotech companies
  • Number of domestic and worldwide licensing for privately-owned biotech
    companies
  • Number of R&D and commercialization licensing for privately-owned
    biotech companies
  • Number of licensing deals discontinued for privately-owned biotech
    companies

For more information about this report visit https://www.researchandmarkets.com/research/t5cwzr/2018_global?w=4

View Comments and Join the Discussion!